Alvotech Bullish As Facility Deficiencies Hold Up Humira Biosimilar Again

AVT02 Higher-Concentration Adalimumab Formulation Previously Delayed

 
• By Dean Rudge
  
Illustration of businessman jumping over hurdle
Alvotech has a hurdle to clear • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products